| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 29, 2022 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 100,000 | $1.07 | $107,100.00 | +0.1% | - | - | |
| Dec 28, 2022 | ITHUF Ianthus Capital Holdings, Inc. | Gotham Green Partners LLC | 10% Owner | Sell | 4,116,051 | $0.00 | - | -0.3% | - | - | |
| Dec 28, 2022 | CGC Canopy Growth Corp | Yanofsky Theresa75 | Director | Sell | 3,717 | $2.97 | $11,039.49 | -12.9% | -17.4% | -75.8% | |
| Dec 28, 2022 | CGC Canopy Growth Corp | Lazzarato David Angelo75 | Director | Sell | 3,733 | $2.97 | $11,087.01 | -15.9% | -17.4% | -75.8% | |
| Dec 28, 2022 | CGC Canopy Growth Corp | Schmeling Judy56 | Director | Sell | 1,792 | $2.97 | $5,322.24 | -3.0% | -17.4% | -75.8% | |
| Dec 28, 2022 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $274.02 | $4,384,339.58 | -38.0% | -19.9% | -19.8% | |
| Dec 27, 2022 | COLL Collegium Pharmaceutical, Inc | Ciaffoni Joseph | President And CEO | Sell | 2,461 | $23.67 | $58,251.60 | -0.2% | +2.5% | +30.7% | |
| Dec 27, 2022 | COLL Collegium Pharmaceutical, Inc | Heffernan Michael Thomas | Director | Sell | 25,041 | $23.58 | $590,451.05 | -18.3% | +2.5% | +30.7% | |
| Dec 23, 2022 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Sell | 2,149,847 | $0.00 | - | -2.4% | - | - | |
| Dec 23, 2022 | AVDL Avadel Pharmaceuticals Plc | Palczuk Linda78 | Director | Buy | 2,000 | $7.20 | $14,405.00 | +4.2% | +30.9% | +97.7% | |
| Dec 23, 2022 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $276.27 | $4,420,255.12 | -39.4% | -22.5% | -21.5% | |
| Dec 22, 2022 | HROW Harrow, Inc. | Baum Mark L66 | Chief Executive Officer | Buy | 25,000 | $13.39 | $334,750.00 | +1.8% | +28.0% | -21.6% | |
| Dec 22, 2022 | HROW Harrow, Inc. | Boll Andrew R. | Chief Financial Officer | Buy | 2,500 | $13.54 | $33,850.00 | +1.0% | +28.0% | -21.6% | |
| Dec 22, 2022 | HROW Harrow, Inc. | Van Horn R. Lawrence | Director | Buy | 1,860 | $13.42 | $24,961.20 | New | +28.0% | -21.6% | |
| Dec 21, 2022 | HROW Harrow, Inc. | Makary Martin A. | Director | Buy | 25,000 | $13.37 | $334,250.00 | New | +32.6% | -21.6% | |
| Dec 21, 2022 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $273.59 | $4,377,509.98 | -28.4% | -18.8% | -20.3% | |
| Dec 21, 2022 | SUPN Supernus Pharmaceuticals, Inc. | Khattar Jack A.64 | President, CEO | Sell | 15,360 | $38.11 | $585,386.88 | -0.9% | -3.1% | -24.5% | |
| Dec 21, 2022 | COLL Collegium Pharmaceutical, Inc | Ciaffoni Joseph | President And CEO | Sell | 17,842 | $23.08 | $411,840.22 | -2.2% | +8.2% | +32.4% | |
| Dec 21, 2022 | COLL Collegium Pharmaceutical, Inc | Heffernan Michael Thomas | Director | Sell | 83,964 | $23.09 | $1,939,142.88 | -50.0% | +8.2% | +32.4% | |
| Dec 21, 2022 | CPIX Cumberland Pharmaceuticals Inc | Galante Joseph C47 | Director | Buy | 1,550 | $2.22 | $3,446.50 | +0.2% | -6.6% | -19.4% | |
| Dec 21, 2022 | CPIX Cumberland Pharmaceuticals Inc | Krogulski Kenneth54 | Director | Buy | 3,050 | $2.22 | $6,778.28 | +0.1% | -6.6% | -19.4% | |
| Dec 21, 2022 | CPIX Cumberland Pharmaceuticals Inc | Jones James53 | Director | Buy | 667 | $2.23 | $1,486.85 | +0.2% | -6.6% | -19.4% | |
| Dec 20, 2022 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | Director, 10% Owner | Buy | 125,000 | $0.04 | $4,891.00 | - | - | - | |
| Dec 20, 2022 | CPIX Cumberland Pharmaceuticals Inc | Young Caroline52 | Director | Buy | 379 | $2.24 | $848.69 | +0.1% | -7.4% | -19.4% | |
| Dec 19, 2022 | AYTU Aytu Biopharma, Inc | Pyszczymuka Greg | Chief Commercial Officer | Buy | 100,000 | $0.24 | $24,480.00 | +121.9% | -53.3% | -33.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.